多西環素用于喹諾酮類治療失敗的大環內酯類耐藥肺炎支原體肺炎一例_West China Medical Journal

Authors：

文穎燕 , 陳俊珊 , 詹偉杰 , 簡小云 ,  李家春

廣州中醫藥大學第八臨床醫學院（廣東佛山 528000）;

Corresponding?author：

李家春, Email: 398149605@qq.com

Keywords：

肺炎支原體肺炎; 宏基因組學第二代測序; 大環內酯類耐藥; 喹諾酮類; 多西環素

DOI：

10.7507/1002-0179.202402199

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 文穎燕, 陳俊珊, 詹偉杰, 簡小云, 李家春. 多西環素用于喹諾酮類治療失敗的大環內酯類耐藥肺炎支原體肺炎一例. West China Medical Journal, 2024, 39(8): 1333-1334. doi: 10.7507/1002-0179.202402199 Copy

1.	中華醫學會呼吸病學分會. 中國成人社區獲得性肺炎診斷和治療指南(2016 年版). 中華結核和呼吸雜志, 2016, 39(4): 253-279.
2.	Zhou Y, Zhang Y, Sheng Y, et al. More complications occur in macrolide-resistant than in macrolide-sensitive Mycoplasma pneumoniae pneumonia. Antimicrob Agents Chemother, 2014, 58(2): 1034-1038.
3.	Cao B, Zhao CJ, Yin YD, et al. High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China. Clin Infect Dis, 2010, 51(2): 189-194.
4.	高恒妙, 錢素云. 難治性、暴發性及大環內酯類耐藥肺炎支原體肺炎的治療. 中國小兒急救醫學, 2021, 28(1): 1-6.
5.	中華醫學會兒科學分會臨床檢驗學組. 兒童肺炎支原體呼吸道感染實驗室診斷中國專家共識. 中華檢驗醫學雜志, 2019, 42(7): 507-513.
6.	馮雪莉, 李勤靜, 徐保平, 等. RNA 恒溫擴增檢測技術在兒童肺炎支原體肺炎中的診斷價值評估. 中華實用兒科臨床雜志, 2016, 31(16): 1222-1226.
7.	葛夢蕾, 殷芳, 趙漢青, 等. 肺炎支原體抗體滴度和 RNA 檢測在兒童肺炎支原體肺炎診療中的應用價值. 中華檢驗醫學雜志, 2020, 43(11): 1106-1111.
8.	《中華傳染病雜志》編輯委員會. 中國宏基因組學第二代測序技術檢測感染病原體的臨床應用專家共識. 中華傳染病雜志, 2020, 38(11): 681-689.
9.	中華醫學會呼吸病學分會感染學組. 成人肺炎支原體肺炎診治專家共識. 中華結核和呼吸雜志, 2010, 33(9): 643-645.
10.	Couldwell DL, Tagg KA, Jeoffreys NJ, et al. Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance. Int J STD AIDS, 2013, 24(10): 822-828.
11.	Pereyre S, Goret J, Bébéar C. Mycoplasma pneumoniae: current knowledge on macrolide resistance and treatment. Front Microbiol, 2016, 7: 974.
12.	Morozumi M, Okada T, Tajima T, et al. Killing kinetics of minocycline, doxycycline and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae. Int J Antimicrob Agents, 2017, 50(2): 255-257.

1. 中華醫學會呼吸病學分會. 中國成人社區獲得性肺炎診斷和治療指南(2016 年版). 中華結核和呼吸雜志, 2016, 39(4): 253-279.
2. Zhou Y, Zhang Y, Sheng Y, et al. More complications occur in macrolide-resistant than in macrolide-sensitive Mycoplasma pneumoniae pneumonia. Antimicrob Agents Chemother, 2014, 58(2): 1034-1038.
3. Cao B, Zhao CJ, Yin YD, et al. High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China. Clin Infect Dis, 2010, 51(2): 189-194.
4. 高恒妙, 錢素云. 難治性、暴發性及大環內酯類耐藥肺炎支原體肺炎的治療. 中國小兒急救醫學, 2021, 28(1): 1-6.
5. 中華醫學會兒科學分會臨床檢驗學組. 兒童肺炎支原體呼吸道感染實驗室診斷中國專家共識. 中華檢驗醫學雜志, 2019, 42(7): 507-513.
6. 馮雪莉, 李勤靜, 徐保平, 等. RNA 恒溫擴增檢測技術在兒童肺炎支原體肺炎中的診斷價值評估. 中華實用兒科臨床雜志, 2016, 31(16): 1222-1226.
7. 葛夢蕾, 殷芳, 趙漢青, 等. 肺炎支原體抗體滴度和 RNA 檢測在兒童肺炎支原體肺炎診療中的應用價值. 中華檢驗醫學雜志, 2020, 43(11): 1106-1111.
8. 《中華傳染病雜志》編輯委員會. 中國宏基因組學第二代測序技術檢測感染病原體的臨床應用專家共識. 中華傳染病雜志, 2020, 38(11): 681-689.
9. 中華醫學會呼吸病學分會感染學組. 成人肺炎支原體肺炎診治專家共識. 中華結核和呼吸雜志, 2010, 33(9): 643-645.
10. Couldwell DL, Tagg KA, Jeoffreys NJ, et al. Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance. Int J STD AIDS, 2013, 24(10): 822-828.
11. Pereyre S, Goret J, Bébéar C. Mycoplasma pneumoniae: current knowledge on macrolide resistance and treatment. Front Microbiol, 2016, 7: 974.
12. Morozumi M, Okada T, Tajima T, et al. Killing kinetics of minocycline, doxycycline and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae. Int J Antimicrob Agents, 2017, 50(2): 255-257.

Previous Article
Relationship between branched-chain amino acids and aging and health of the elderly
Next Article
三種腫瘤合并致難治性高血鈣一例

West China Medical Journal

多西環素用于喹諾酮類治療失敗的大環內酯類耐藥肺炎支原體肺炎一例

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content